“…It is known that the p53-dependent mechanism involves inhibition of p53 activity by MDM2, by direct-binding (Momand et al, 1992), shuttling p53 from the nucleus to the cytoplasm (Tao and Levine, 1999), and inducing ubiquitination and hence degradation by the ubiquitin-proteasome system (Haupt et al, 1997). Several lines of evidence support a role for p53-independent functions of MDM2 in tumor formation (Bouska et al, 2008;Ganguli and Wasylyk, 2003).…”